Atea Pharmaceuticals
AVIR
#7534
Rank
HK$2.18 B
Marketcap
HK$25.91
Share price
-0.89%
Change (1 day)
15.16%
Change (1 year)

EPS for Atea Pharmaceuticals (AVIR)

EPS in 2023 (TTM): -HK$10.03

According to Atea Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$9.96. In 2022 the company made an earnings per share (EPS) of -HK$10.89 a decrease over its 2021 EPS that were of HK$11.36.

EPS history for Atea Pharmaceuticals from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$10.03-7.92%
2022-HK$10.89-195.89%
2021HK$11.36-645.91%
2020-HK$2.08

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$16.96 70.31%๐Ÿ‡บ๐Ÿ‡ธ USA